ArticleCureus2026
The Conundrum of the National Exit Test (NExT) in India.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The National Exit Test (NExT) has emerged as a contentious issue in the landscape of Indian healthcare education. With a historical backdrop of evolving medical education and the pressing need for quality healthcare for all, NExT aims to standardize medical graduate competency levels. While the intent is laudable, the proposal has triggered intense debates. NExT's proponents argue that standardization will raise educational quality, ensuring minimum competence among medical professionals. It also seeks to bridge the gap between theory and practice, better preparing graduates for evolving healthcare demands. Additionally, NExT promises equal opportunities for all students, addressing issues of regional disparities and limited seats. However, NExT faces criticism for potentially homogenizing curricula, neglecting specialization, and burdening students and institutions. Drawing lessons from international counterparts, such as the United States Medical Licensing Examination (USMLE) and the United Kingdom Foundation Programme (UKFP), India can strike a balance by incorporating flexibility into assessments and investing in infrastructure. Ongoing evaluation and adaptation of NExT will be crucial to mitigate unintended consequences. As of the most recent update, the NMC has postponed NExT, indicating its significance and complexity. NExT regulations propose a two-phase examination with implications for internships and postgraduate course entrance, aiming to validate graduates' eligibility for medical practice and specialization. In conclusion, India faces the challenge of harmonizing quality and equity in healthcare education through NExT. By learning from global experiences and adopting an inclusive, adaptable approach, India can navigate this conundrum and produce competent healthcare professionals ready to meet the diverse needs of its population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.